RhumbLine Advisers’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.11M	Sell	142,584 -2,112	-1%	-$30.9K	﹤0.01%	1824
2025 Q4	$2.31M	Sell	144,696 -26,443	-15%	-$375K	﹤0.01%	1799
2025 Q3	$1.89M	Sell	171,139 -5,627	-3%	-$61.5K	﹤0.01%	1944
2025 Q2	$1.5M	Sell	176,766 -16,969	-9%	-$136K	﹤0.01%	2041
2025 Q1	$1.56M	Buy	193,735 +124	+0.1%	+$1K	﹤0.01%	1944
2024 Q4	$1.74M	Sell	193,611 -180	-0.1%	-$1.47K	﹤0.01%	1962
2024 Q3	$1.42M	Sell	193,791 -14,472	-7%	-$89.7K	﹤0.01%	2084
2024 Q2	$1.19M	Buy	208,263 +24,371	+13%	+$128K	﹤0.01%	2149
2024 Q1	$921K	Buy	183,892 +2,548	+1%	+$17.3K	﹤0.01%	2297
2023 Q4	$1.63M	Buy	181,344 +664	+0.4%	+$5.47K	﹤0.01%	2009
2023 Q3	$1.4M	Buy	180,680 +1,554	+0.9%	+$15.2K	﹤0.01%	2027
2023 Q2	$1.73M	Buy	179,126 +5,624	+3%	+$58.4K	﹤0.01%	1985
2023 Q1	$1.9M	Buy	173,502 +6,949	+4%	+$61.2K	﹤0.01%	1831
2022 Q4	$720K	Buy	166,553 +2,672	+2%	+$15.5K	﹤0.01%	2296
2022 Q3	$1.23M	Buy	163,881 +12,005	+8%	+$104K	﹤0.01%	2028
2022 Q2	$1.53M	Buy	+151,876	New	+$1.7M	﹤0.01%	1918